Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Nov 9 - Nov 14
Injections (subcutaneous semaglutide or tirzepatide) are the established, clinically studied route with predictable blood levels and robust weight-loss outcomes
Other companies are working on their own weight-loss pills: Eli Lilly, which makes Zepbound, is developing a GLP-1 pill, orforglipron, for weight loss and type 2 diabetes, with FDA approval anticipated for March 2026
Informed Sport certified, it supports brain and cardiovascular health while increasing muscle strength, power, and lean mass
In a cohort study of 18,386 adults with overweight or obesity, the average reduction in body weight after three months of treatment for tirzepatide users was 5.9% compared to 3.6% for semaglutide users
![Tirzepatide vs. Semaglutide: Which Weight Loss Drug Works Better? [May 2025 NEJM Study Explained]](https://belite.com/wp-content/uploads/2025/06/July-2025-Blog-Post-Belite.png)
US$ 28.73
US$ 20.95
US$ 24.45
